GMP Standard Tirzepatide 20mg Production - LY3298176 API Intermediate Supplier

Tirzepatide 20mg is a dual GLP-1 and GIP receptor agonist primarily developed for type 2 diabetes research applications. This innovative peptide demonstrates superior glucose-dependent insulin secretion properties while simultaneously suppressing glucagon release.

The molecular mechanism of tirzepatide 20mg involves activation of both GLP-1 and GIP receptors, creating a synergistic effect that enhances glycemic control. Research indicates this dual agonism may offer advantages over single-receptor agonists in metabolic studies.

Our pharmaceutical grade tirzepatide 20mg is manufactured under strict GMP conditions, ensuring batch-to-batch consistency and purity exceeding 99%. The product is supplied in sterile vials with multiple packaging configurations available to meet various research requirements.

Important Note: This product is intended for research use only by qualified professionals. Not for human consumption or diagnostic use.

Storage conditions for tirzepatide 20mg require refrigeration (2-8°C) in its original packaging. When handled properly under laboratory conditions, the compound maintains stability throughout its shelf life.

For research institutions requiring bulk quantities of tirzepatide 20mg, we offer customized manufacturing solutions with flexible order quantities and purity specifications. Our technical team can provide additional analytical data and certificates upon request.